Stockholders' Equity (Tables)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2020 |
Dec. 31, 2019 |
Equity [Abstract] |
|
|
Schedule of Stock Option Cancelled |
The number of options cancelled to our officers
and directors were as follows:
David Phipps, President, CEO, and Director |
|
|
(5,000 |
) |
Theresa Carlise, CFO |
|
|
(2,500 |
) |
Hector Delgado, Director |
|
|
(1,250 |
) |
|
The number of options cancelled to our officers
and directors were as follows:
David Phipps, President, CEO, and Director |
|
|
(5,000 |
) |
Theresa Carlise, CFO |
|
|
(2,500 |
) |
Hector Delgado, Director |
|
|
(1,250 |
) |
|
Schedule of Exercise of Shares |
|
|
Options
Exercised |
|
|
Exercise
Price |
|
|
Market
Price |
|
|
Shares
withheld as
Payment |
|
|
Common
Stock
Issued |
|
David Phipps |
|
|
21,667 |
|
|
$ |
2.55 |
|
|
$ |
5.25 |
|
|
|
10,524 |
|
|
|
11,143 |
|
Other |
|
|
18,333 |
|
|
$ |
2.25 |
|
|
$ |
5.25 |
|
|
|
7,857 |
|
|
|
10,476 |
|
|
|
|
40,000 |
|
|
|
|
|
|
|
|
|
|
|
18,381 |
|
|
|
21,619 |
|
|
|
Options
Exercised |
|
|
Exercise
Price |
|
|
Market
Price |
|
|
Shares
withheld as
Payment |
|
|
Common
Stock
Issued |
|
David Phipps |
|
|
400,000 |
|
|
$ |
0.20 |
|
|
$ |
0.25 |
|
|
|
80,000 |
|
|
|
320,000 |
|
Other |
|
|
110,000 |
|
|
$ |
0.20 |
|
|
$ |
0.25 |
|
|
|
22,000 |
|
|
|
88,000 |
|
|
|
|
510,000 |
|
|
|
|
|
|
|
|
|
|
|
102,000 |
|
|
|
408,000 |
|
|
As a result of the exercise
21,619 shares of common stock were issued.
|
|
Options
Exercised |
|
|
Exercise
Price |
|
|
Market
Price |
|
|
Shares
withheld as
Payment |
|
|
Common
Stock
Issued |
|
David Phipps |
|
|
21,667 |
|
|
$ |
2.55 |
|
|
$ |
5.25 |
|
|
|
10,524 |
|
|
|
11,143 |
|
Other |
|
|
18,333 |
|
|
$ |
2.25 |
|
|
$ |
5.25 |
|
|
|
7,857 |
|
|
|
10,476 |
|
|
|
|
40,000 |
|
|
|
|
|
|
|
|
|
|
|
18,381 |
|
|
|
21,619 |
|
|
Schedule of Outstanding Stock Options Activities |
A summary of the status
of the Company’s outstanding stock options and changes during the nine months ended September 30, 2020 is as follows:
|
|
Number of
Options |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Life
(Years) |
|
Balance at January 1, 2020 |
|
|
39,044 |
|
|
$ |
17.49 |
|
|
|
5.16 |
|
Granted |
|
|
817,000 |
|
|
|
0.20 |
|
|
|
9.90 |
|
Exercised |
|
|
(531,000 |
) |
|
|
0.20 |
|
|
|
9.89 |
|
Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding at September 30, 2020 |
|
|
325,044 |
|
|
$ |
2.28 |
|
|
|
9.25 |
|
Options exercisable at September 30, 2020 |
|
|
325,044 |
|
|
$ |
2.28 |
|
|
|
9.25 |
|
|
A summary of the status
of the Company’s outstanding stock options and changes during the years ended December 31, 2019 and 2018, is as follows:
|
|
Number of
Options |
|
|
Weighted
Average Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual Life
(Years) |
|
Balance at January 1, 2018 |
|
|
19,044 |
|
|
$ |
29.25 |
|
|
|
9.01 |
|
Granted |
|
|
73,750 |
|
|
$ |
7.50 |
|
|
|
4.35 |
|
Exercised |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Cancelled |
|
|
(13,750 |
) |
|
$ |
23.10 |
|
|
|
2.50 |
|
Balance outstanding at December 31, 2018 |
|
|
79,044 |
|
|
$ |
9.90 |
|
|
|
5.56 |
|
Options exercisable at December 31, 2018 |
|
|
79,044 |
|
|
|
|
|
|
|
|
|
Weighted average fair value of options granted during the period |
|
|
|
|
|
$ |
7.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2019 |
|
|
79,044 |
|
|
$ |
9.90 |
|
|
|
5.56 |
|
Granted |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Exercised |
|
|
(40,000 |
) |
|
$ |
2.41 |
|
|
|
4.72 |
|
Forfeited |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Cancelled |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Balance outstanding at December 31, 2019 |
|
|
39,044 |
|
|
$ |
17.49 |
|
|
|
5.16 |
|
Options exercisable at December 31, 2019 |
|
|
39,044 |
|
|
$ |
17.49 |
|
|
|
5.16 |
|
Weighted average fair value of options granted during the period |
|
|
|
|
|
$ |
- |
|
|
|
- |
|
|
Schedule of Outstanding Stock Warrants Activities |
A summary of the status
of the Company’s outstanding warrants and changes during the nine months ended September 30, 2020 is as follows:
|
|
Number of
Warrants |
|
|
Weighted
Average Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Life
(Years) |
|
Balance at January 1, 2020 |
|
|
4,000 |
|
|
$ |
60.00 |
|
|
|
0.62 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding and exercisable at September 30, 2020 |
|
|
4,000 |
|
|
$ |
60.00 |
|
|
|
0.62 |
|
|
A summary of the status
of the Company’s outstanding stock warrants and changes during the years ended December 31, 2019 and 2018, is as follows:
|
|
Number of
Warrants |
|
|
Weighted
Average Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual Life
(Years) |
|
Balance at January 1, 2018 |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
Granted |
|
|
4,000 |
|
|
|
60.00 |
|
|
|
2.37 |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
Cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance at December 31, 2018 |
|
|
4,000 |
|
|
$ |
60.00 |
|
|
|
2.37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2019 |
|
|
4,000 |
|
|
$ |
60.00 |
|
|
|
2.37 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding at December 31, 2019 |
|
|
4,000 |
|
|
$ |
60.00 |
|
|
|
1.37 |
|
|